Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.7B | 1.6B | 1.7B |
Cost of revenue | 461M | 539M | 496M | 481M |
Gross profit | 1.1B | 1.2B | 1.1B | 1.2B |
Operating expense | ||||
Research & development | 242M | 256M | 247M | 257M |
Selling general and admin | 545M | 543M | 525M | 562M |
Other operating expenses | — | — | — | — |
Operating income | 311M | 394M | 373M | 358M |
Non operating interest income | ||||
Income | 36M | 29M | 20M | 27M |
Expense | 29M | 21M | 12M | 15M |
Other income expense | -14M | -48M | -11M | -10M |
Pretax income | 304M | 354M | 370M | 360M |
Tax provision | 71M | 14M | 71M | 61M |
Net income | 233M | 340M | 299M | 299M |
Basic EPS | 1.2 | 1.7 | 1.5 | 1.5 |
Diluted EPS | 1.2 | 1.7 | 1.4 | 1.4 |
Basic average shares | 201M | 203M | 204M | 204M |
Diluted average shares | 203M | 206M | 208M | 210M |
EBITDA | 386M | 474M | 457M | 451M |
Net income from continuing op. | 233M | 340M | 299M | 299M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |